Warren Buffetts Berkshire Hathaway Sells Merck Shares, Buys Royalty Pharma – Barrons

Berkshire Hathaway sold its equity holding in Merck and continued to pare its investments in two other drug companies, AbbVie and Bristol Myers Squibb, during the third quarter, according to the company’s 13-F filing released late Monday.

Berkshire (ticker: BRK.A and BRK.B) added to its stake in Chevron (CVX) and showed a new holding of $475 million in Royalty Pharma (RPRX), a company that invests in drug royalties.


Leave a comment

Your email address will not be published. Required fields are marked *